A Clinical Investigation to Determine the Safety and Efficacy of a Novel, Patented Prunus Domestica Extract in Benign Prostatic Hyperplasia (BPH)
Abstract
Background: The non-cancerous enlargement of the prostate gland frequently seen in males ofage over 50 years is known as Benign Prostate Hyperplasia (BPH). The major symptoms andailments of the disease involve difficulty in urination with dripping of urine, incompleteemptying of the urinary bladder and backflow of urine in extreme cases which may result inkidney infection. The conventional drugs based on alpha-adrenergic receptor antagonists or theType 2 5-alpha reductase inhibitors both of which have been found to be associated with seriousside effects. Phototherapeutics, especially phytosterols from the plum family, Prunus domesticaand Prunus africana have shown promising results in treatment of BPH especially throughreduction of prolactin levels and arresting accumulation of cholesterol in Prostate.Objectives: The present research was undertaken to carry out a robust clinical trial on the effectof Prosman TM , a novel patented and standardized extract of Prunus domestica in patientssuffering from BPH belonging in the age group of 40-65 years.Material and Methods: An open labeled single armed study in 140 male patients of BPH withinthe age group of 40-65 years. Prosman TM in dosage of 100 mg was administered twice a day for12 weeks with follow-ups at the end of 4, 8 and 12 weeks. Subsequently the efficacy of theproduct was assessed by biochemical tests including blood test for Prostate Specific antigen
(PSA), Ultrasound and urinary flow test. Safety was ascertained through…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.